Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.

Specialty Pharmacy: The Trends Shaping Best Practices

New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines. 

Eli Lilly, Johnson & Johnson Invest in New Drug Manufacturing Facilities

Vice President of Life Sciences at Kenco.

Various forms of technology—including in the serialization and refrigeration spaces—are necessary in order to keep goods flowing smoothly through the supply chain. 

Three Key Pharmaceutical Logistics Challenges to Monitor 

The company—whose foundation has committed $1.5 million for in donations for recovery—is currently working on a plan that will help limit supply disruption. 

Baxter North Cove Plant Currently Closed Due to Hurricane Helene

Videos

In the final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, predicts how the future of data accessibility will unfold.

The Future of Supply Chain Visibility

The latest news for pharma industry insiders.

Pharma Pulse 10/2/24: Creating a Digitized Supply Chain, Factors to Consider When Switching Therapies & more

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery. 

Keeping Do-Not-Freeze Injectable Drugs Safe Through the Last Mile 

Managing partner at Numerof & Associates.

How can buyers maximize the value of their acquisitions?

Key Elements for Success in Pharma M&A Integration

Are these statistical characteristics—along with social determinants of health—associated with denials of preventive care claims?

The Connection Between Patient Demographics and Insurance Denials

In the third part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, details the importance of E2E visibility. 

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right